Neeraj Jain: Maharashtra Strengthens Hemoglobinopathies and Thalassemia Care Through Integrated Public Health Collaboration
Neeraj Jain, Director of Growth Operations – Asia, Middle East and Europe (AMEE) at PATH, shared Maharashtra Arogya IEC Bureau’s post on LinkedIn, adding:
“Maharashtra continues to be at the forefront of strengthening the response to hemoglobinopathies.
This expert consultation, led by the Public Health Department, Maharashtra, marks an important step towards building a more coordinated, equitable, and sustainable approach to addressing hemoglobinopathies and hemophilia.
PATH remains committed to working alongside governments and partners to strengthen the prevention, diagnosis, and management of hemoglobinopathies through integrated, people-centred approaches.
Grateful to BMS Foundation and Catharine Grimes, MBA, for their continued support in advancing integrated approaches to hemoglobinopathies, with a focus on thalassemia, in Maharashtra.”
Maharashtra Arogya IEC Bureau shared a post on LinkedIn:
“Maharashtra has taken a significant step towards strengthening the prevention, diagnosis, treatment, and care of hemoglobinopathies and hemophilia through a comprehensive and integrated approach.
A lively and thought-provoking exchange of ideas marked the Maharashtra Integrated Haemoglobinopathies and Hemophilia Elimination Initiative (MHEI 2026), held in Mumbai on 18 June 2026.
Convened by the Public Health Department, Government of Maharashtra, in collaboration with National Health Mission Maharashtra and PATH, the expert consultation brought together policymakers, clinicians, researchers, technical experts, and implementation partners to deliberate
on a roadmap for the prevention, control, and comprehensive management of Sickle Cell Disease, Thalassemia, and Hemophilia in Maharashtra, while exploring a key question
How can Maharashtra build an integrated, equitable, and sustainable state-wide programme for the prevention, diagnosis, treatment, and long-term management of hemoglobinopathies and hemophilia?
The consultation focused on strengthening the entire continuum of care—from screening, diagnosis, prevention, counselling, and comprehensive treatment to patient support systems, day-care services, human resources, financing, surveillance, and community engagement.
The recommendations emerging from this consultation will help shape Maharashtra’s roadmap towards a more coordinated, equitable, and sustainable response to hemoglobinopathies and hemophilia, ultimately improving the quality of life and health outcomes of affected individuals and families across the state.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026